Jounce Therapeutics (JNCE)

3.32 -0.11 (3.21%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/9/18 *Est.)

Latest Headlines

Form SC 13G/A Jounce Therapeutics, Filed by: FMR LLC December 10, 2018 9:03 AM - SEC Filing Report: Exploring Fundamental Drivers Behind Matrix Service, NantHealth, Earthstone Energy, Jounce Therapeutics, BeiGene, and Oxford Immunotec Global — New Horizons, Emerging Trends, and Upcoming De November 28, 2018 9:00 AM - Globe NewsWire Baker Bros. Advisors 13F for Quarter Ended Sept. 30, 2018 November 14, 2018 4:55 PM - StreetInsider JPMorgan Downgrades Jounce Therapeutics (JNCE) to Underweight November 14, 2018 4:57 AM - StreetInsider Form 10-Q Jounce Therapeutics, For: Sep 30 November 13, 2018 11:06 AM - SEC Filing Form 8-K Jounce Therapeutics, For: Nov 13 November 13, 2018 7:07 AM - SEC Filing Jounce Therapeutics Reports Third Quarter 2018 Financial Results November 13, 2018 6:30 AM - Globe NewsWire Jounce Therapeutics Presents Reverse Translational, Biomarker and Preclinical Data from ICOS Program at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting November 10, 2018 12:20 PM - Globe NewsWire Form 8-K Jounce Therapeutics, For: Nov 09 November 9, 2018 8:08 AM - SEC Filing Jounce Therapeutics to Announce Third Quarter 2018 Financial Results and Host Conference Call on Tuesday, November 13, 2018 November 6, 2018 8:00 AM - Globe NewsWire Jounce Therapeutics to Present Two Posters from the JTX-2011 Program at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting November 2, 2018 1:48 PM - Globe NewsWire New Research Coverage Highlights Himax Technologies, Corporacion America Airports S.A, Tecnoglass, Jounce Therapeutics, Hollysys Automation Technologies, and Obsidian Energy — Consolidated Revenues, October 19, 2018 9:15 AM - Globe NewsWire Jounce Therapeutics Founder Dr. James P. Allison Jointly Awarded 2018 Nobel Prize in Physiology or Medicine for the Discovery of Cancer Therapy by Inhibition of Negative Immune Regulation October 1, 2018 11:39 AM - Globe NewsWire Jounce Therapeutics to Present at the 2018 Cantor Global Healthcare Conference September 26, 2018 8:00 AM - Globe NewsWire Full Article List